From September 23rd to the 26th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Associate Scientific Director of Protein Therapeutics.  Dr. Roberts will present two posters on Tuesday September 24th, from 3:30PM – 5:30PM local time.  The posters will include a look at our What If Machine (WhIM) for a case study on Taspoglutide highlighting our PANDA process


The Boulder Peptide Society is a non-profit 501(3)c organization dedicated to supporting the advancement of peptide therapeutics.  Each year, the organization hosts the Boulder Peptide Symposium which is a key vehicle for driving the science and technology in this important field.  The Boulder Peptide Symposium seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. Peptide therapeutics are potent and highly selective yet their development into effective treatments can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape. BPS is the key forum where these challenges will be identified, discussed, and one day—addressed.

For more information on the BPS and/or to register for the symposium please visit the event page.